Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Trevi Therapeutics, Inc.”

7 pharma patents match "Trevi Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Trevi Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Trevi Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12274696

    Methods of administering nalbuphine

    Trevi Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  2. US 11660296

    Treatment of chronic cough, breathlessness and dyspnea

    Trevi Therapeutics, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  3. US 10238646

    Methods for treating pruritus

    Trevi Therapeutics, Inc. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted
  4. US 9624233

    Compounds for treating pruritic conditions

    Trevi Therapeutics, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  5. US 8987289

    Methods for treating pruritus

    Trevi Therapeutics, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  6. US 8940753

    Methods for treating pruritis

    Trevi Therapeutics, Inc. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted
  7. US 8637538

    Methods for treatment of pruritis

    Trevi Therapeutics, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted